Our World in Words and Film

08/25/2026

Farmers Have Sprayed It for Decades. A New Bill Wants to Ban It Nationwide, Citing Parkinson’s Risk.

A bipartisan bill in Congress seeks to ban paraquat, a widely used herbicide linked in research to an increased risk of Parkinson’s disease. Parkinson’s organizations are backing the effort as lawmakers face renewed pressure to remove the chemical from U.S. agriculture....

A bipartisan bill in Congress seeks to ban paraquat, a widely used herbicide linked in research to an increased risk of Parkinson’s disease. Parkinson’s organizations are backing the effort as lawmakers face renewed pressure to remove the chemical from U.S. agriculture.

08/25/2026

Two paths to steadier Parkinson’s treatment, one shows promise, one shows a warning sign

This week in Parkinson’s: New research highlights advances in treating motor fluctuations while raising new questions about the real-world safety of continuous levodopa therapy....

This week in Parkinson’s: New research highlights advances in treating motor fluctuations while raising new questions about the real-world safety of continuous levodopa therapy.

08/18/2026

Could Changing the Frequency of Deep Brain Stimulation Help Parkinson’s Cognition?

A small study suggests that slowing deep brain stimulation down to 4 Hz may improve cognitive accuracy in some people with Parkinson’s, raising the possibility that future systems could target motor and cognitive symptoms differently....

A small study suggests that slowing deep brain stimulation down to 4 Hz may improve cognitive accuracy in some people with Parkinson’s, raising the possibility that future systems could target motor and cognitive symptoms differently. Deep brain stimulation has been used for years to control the m...

08/13/2026

Experimental Once-Daily Parkinson’s Drug Shows Promise in Large Trial, but Some Patients Struggled to Tolerate It

A new medication for Parkinson's disease significantly eased motor symptoms and improved daily functioning in a major international trial, though a notably high dropout rate among those taking the drug raises questions about how well patients tolerate it, according to results published in…...

https://themovementdisorderjournal.com/2026/08/13/experimental-once-daily-parkinsons-drug-shows-promise-in-large-trial-but-some-patients-struggled-to-tolerate-it/

08/10/2026

Three Databases, One Pattern: Pesticide-Exposed Parkinson’s Patients Face Broader Symptom Burden

A new longitudinal study out of Charité–Universitätsmedizin Berlin, published this week in npj Parkinson’s Disease, adds substantial weight to one of the field’s most persistent environmental questions: not just whether pesticide exposure raises the risk of developing Parkinson’s, but what happens to symptoms after diagnosis....

A new longitudinal study out of Charité–Universitätsmedizin Berlin, published this week in npj Parkinson’s Disease, adds substantial weight to one of the field’s most persistent environmental questions: not just whether pesticide exposure raises the risk of developing Parkinson’s, but what...

08/05/2026

FDA, Fox Foundation Advance Parkinson’s Cell and Gene Therapies as Research Momentum Build

FDA clears faster path for Parkinson’s cell therapy. SAN DIEGO — The Food and Drug Administration granted Regenerative Medicine Advanced Therapy designation July 30 to sasineprocel, an experimental cell therapy developed by…...

FDA clears faster path for Parkinson’s cell therapy. SAN DIEGO — The Food and Drug Administration granted Regenerative Medicine Advanced Therapy designation July 30 to sasineprocel, an experimental cell therapy developed by Aspen Neuroscience to treat Parkinson’s disease. The designation, base...

07/24/2026

Huntington’s Update: Two Oral Treatments Advance as Researchers Push to Intervene Earlier

Two experimental pills are advancing through large Huntington's disease trials, even as researchers turn their attention to a genetic process that may be quietly damaging brain cells years before symptoms ever appear....

https://themovementdisorderjournal.com/2026/07/24/huntingtons-update-two-oral-treatments-advance-as-researchers-push-to-intervene-earlier/

07/22/2026

Parkinson’s News This Week: Federal Planning, Early Drug Data and New Rehabilitation Research

The past week brought no major Parkinson’s drug approval or decisive late-stage clinical trial result, but several developments offered a closer look at where research, treatment and federal planning may be heading....

The past week brought no major Parkinson’s drug approval or decisive late-stage clinical trial result, but several developments offered a closer look at where research, treatment and federal planning may be heading. The news ranged from the next meeting of the federal Parkinson’s advisory counci...

07/19/2026

Inside a Big Week for Parkinson’s Research: Stem Cells, a New Culprit Protein, a Possible Shield for Dying Neurons https://themovementdisorderjournal.com/2026/07/15/inside-a-big-week-for-parkinsons-research-stem-cells-a-new-culprit-protein-and-a-possible-shield-for-dying-neurons

07/19/2026

Huntington’s Research Brings New Trials, New Hope, and Another Reminder of the Risks - https://themovementdisorderjournal.com/2026/07/16/huntingtons-research-brings-new-trials-new-hope-and-another-reminder-of-the-risks/